Key Points

  • American Express and Verizon will report quarterly earnings before Friday's market open.
  • American Express will provide insight into consumer spending, while Verizon's results will highlight subscriber growth and operational efficiency.
  • Investors will compare growth prospects at American Express with Verizon's defensive valuation and dividend appeal.
hero

Wall Street will turn its attention to two major blue-chip companies as American Express and Verizon release second-quarter earnings before Friday’s opening bell. While both companies operate in different sectors, their results are expected to provide valuable insight into the health of the U.S. consumer, corporate spending, and broader economic conditions.

For investors, the comparison reflects two distinct investment strategies: American Express offers exposure to consumer and business spending with long-term growth prospects, while Verizon provides a more defensive profile supported by recurring cash flows and dividend income.

American Express Faces High Expectations

American Express enters earnings following a strong long-term share price performance, although its stock has underperformed the broader market so far this year.

Investors will focus on billed business growth, customer spending trends, loan performance, and credit quality to assess whether higher-income consumers continue to demonstrate resilience despite elevated interest rates.

Market participants will also examine management’s outlook for the remainder of the year, particularly regarding travel spending, premium card demand, and provisions for potential credit losses.

Strong earnings and optimistic guidance could reinforce confidence in the company’s long-term growth trajectory, while any indication of slowing consumer activity may weigh on investor sentiment.

Verizon Looks to Extend Operational Momentum

Verizon approaches earnings after outperforming many traditional telecommunications peers during 2026.

Investors will evaluate subscriber additions, wireless service revenue, operating margins, and the effectiveness of the company’s ongoing cost-reduction initiatives. Recent improvements in postpaid customer additions have strengthened confidence that Verizon’s turnaround efforts are gaining traction.

The company’s relatively low valuation compared with the broader market, combined with its attractive dividend yield, continues to make it appealing to income-oriented investors seeking stability during periods of market uncertainty.

Management commentary on capital spending, network investments, and competitive dynamics will also receive close attention.

Growth Versus Stability Defines the Investment Choice

The contrast between the two companies highlights different priorities for investors.

American Express generally appeals to those seeking long-term capital appreciation supported by expanding consumer spending and premium financial services. Its earnings have historically demonstrated resilience, although future performance remains closely linked to economic activity and consumer confidence.

Verizon, by comparison, offers a more defensive investment profile centered on predictable cash generation, lower valuation multiples, and consistent shareholder returns through dividends. Investors are also monitoring emerging long-term competitive risks, including advances in satellite-based communications and continued pricing pressure within the wireless industry.

Ultimately, both earnings reports will provide important signals about the health of key sectors of the U.S. economy, from consumer spending and credit demand to telecommunications services and recurring subscription revenues.

Looking ahead, investor reactions will likely depend not only on whether each company meets quarterly expectations but also on management’s outlook for the second half of the year. Strong guidance from American Express could reinforce confidence in consumer resilience, while continued operational improvement at Verizon would support its position as a stable income-generating investment. Together, the reports are expected to offer valuable insight into both economic conditions and corporate earnings momentum.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast?
    • omer bar
    • •
    • 8 Min Read
    • •
    • ago 2 days

    SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast? SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast?

    Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge

    • ago 2 days
    • •
    • 8 Min Read

    Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge

    SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?
    • Ronny Mor
    • •
    • 6 Min Read
    • •
    • ago 4 days

    SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom? SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?

    Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is

    • ago 4 days
    • •
    • 6 Min Read

    Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is

    SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?
    • Ronny Mor
    • •
    • 7 Min Read
    • •
    • ago 6 days

    SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments? SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?

    Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the

    • ago 6 days
    • •
    • 7 Min Read

    Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the

    SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business?
    • Lior mor
    • •
    • 8 Min Read
    • •
    • ago 6 days

    SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business? SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business?

    Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing

    • ago 6 days
    • •
    • 8 Min Read

    Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing